QDEL
NASDAQ
$16.58
QuidelOrtho Corporation (QDEL)
Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for infectious disease, cardiology, thyroid, general and women's health, eye health, gastrointestinal disease, and toxicology applications globally. The company is headquartered in San Diego, California.
Sector:
Healthcare
Industry:
Medical Devices
Hold
Target: $20.50 (+23.64%)
Market Cap
$1.24B
P/B Ratio
0.66
Free Cash Flow Yield
-12.84%
Beta (5Y)
1.71
Price Chart
Valuation
Market Cap$1.24B
Forward P/E7.23
P/S0.45
P/B0.66
Profitability
Total Revenue (TTM)$2.66B
Gross Profit (TTM)$1.20B
EBITDA-$536M
Profit Margin-14.8%
Operating Margin-5.1%
EPS-$17.84
Financial Health
Debt-to-Equity12.3%
Free Cash Flow Yield-12.84%
Growth & Risk
Beta (5Y)1.71
Sharpe Ratio-0.17